P. Clauson

发表

A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.

L. Gonder-Frederick, D. Wild, R. von Maltzahn, 2007, Patient education and counseling.

Pulmonary insulin administration using the AERx insulin diabetes system.

P. Clauson, J. Thipphawong, J. Okikawa, 2002, Diabetes technology & therapeutics.

Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline Body Mass Index

P. Clauson, K. Rašlová, S. Tamer, 2007, Clinical drug investigation.

Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial

P. Clauson, Y. Iwamoto, K. Kaku, 2012, Journal of diabetes investigation.

The once‐daily human glucagon‐like peptide‐1 analog, liraglutide, improves β‐cell function in Japanese patients with type 2 diabetes

P. Clauson, Y. Seino, K. Kaku, 2012, Journal of diabetes investigation.

Enhancement of B‐cell secretion by blood glucose normalization in type 2 diabetes is associated with fasting C‐peptide levels

P. Clauson, V. Grill, M. Alvarsson, 1997, Journal of internal medicine.

Daytime Glibenclamide and Bedtime NPH Insulin Compared to Intensive Insulin Treatment in Secondary Sulphonylurea Failure: a 1‐Year Follow‐up

P. Clauson, S. Efendić, L. Steen, 1996, Diabetic medicine : a journal of the British Diabetic Association.

The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.

T. Pieber, P. Clauson, B. Ahrén, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Flexible prandial glucose regulation with repaglinide in patients with type 2 diabetes.

P. Clauson, P. Damsbo, T. Marbury, 1999, Diabetes research and clinical practice.

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

G. Charpentier, P. Clauson, B. Thorsteinsson, 2006, Clinical therapeutics.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Absorption of Rapid-Acting Insulin in Obese and Nonobese NIDDM Patients

P. Clauson, B. Linde, 1995, Diabetes Care.

Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink

L. Smeeth, K. Khunti, S. Pocock, 2018, BMC Medicine.

Lower Risk of Hypoglycemia with Insulin Detemir than with Neutral Protamine Hagedorn Insulin in Older Persons with Type 2 Diabetes: A Pooled Analysis of Phase III Trials

P. Clauson, A. Garber, K. Kølendorf, 2007, Journal of the American Geriatrics Society.

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

P. Clauson, P. Damsbo, T. Marbury, 1999, Diabetes care.

Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.

M. Davies, P. Clauson, T. Dereziński, 2008, Diabetes technology & therapeutics.

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.

P. Clauson, V. Grill, K. Brismar, 1998, Scandinavian journal of clinical and laboratory investigation.

Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.

P. Kam, P. Clauson, A. McElduff, 2005, British journal of clinical pharmacology.

Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.

J. Cramer, P. Clauson, J. Okikawa, 2004, Diabetes technology & therapeutics.

Insulin degludec compared with insulin glargine in insulin‐naïve patients with type 2 diabetes: A 26‐week, randomized, controlled, Pan‐Asian, treat‐to‐target trial

P. Clauson, Y. Iwamoto, S. Yoo, 2013, Journal of diabetes investigation.

The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.

T. Pieber, P. Clauson, P. Wollmer, 2008, British journal of clinical pharmacology.

Relationships Between Diabetes Duration, Metabolic Control and β‐cell Function in a Representative Population of Type 2 Diabetic Patients in Sweden

P. Clauson, A. Gottsäter, G. Sundkvist, 1994, Diabetic medicine : a journal of the British Diabetic Association.

Improved glycaemic control with minimal hypoglycaemia and no weight change with the once‐daily human glucagon‐like peptide‐1 analogue liraglutide as add‐on to sulphonylurea in Japanese patients with type 2 diabetes

P. Clauson, Y. Seino, K. Kaku, 2010, Diabetes, obesity & metabolism.